Skip to content

Cognitive Behavioral Therapy for Complicated Grief

Randomized Controlled Clinical Trial of Cognitive Behavioral Therapy for Complicated Grief

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01433653
Acronym
CG-CBT
Enrollment
51
Registered
2011-09-14
Start date
2005-05-31
Completion date
2011-02-28
Last updated
2015-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grief

Keywords

Comorbid, Complicated

Brief summary

The purpose of this study is to determine whether cognitive behavioral therapy (CG-CBT) for complicated grief is superior to wait list condition in patients with comorbid complicated grief. To evaluate the effect pre-post changes for patients in the CG-CBT-group will be compared to changes in the wait list group.

Interventions

BEHAVIORALCognitive Behavioral Therapy for Complicated Grief

Manualized CBT with 25 sessions, once a week. Key elements are exposition and cognitive restructuring.

Sponsors

Ludwig-Maximilians - University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age complicated grief diagnosis

Exclusion criteria

* acute suicidality

Design outcomes

Primary

MeasureTime frame
PG-13 (Prolonged Grief Interview - 13 Item version)Change between intake (t1) and end of treatment (t2) in complicated grief severity within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)

Secondary

MeasureTime frame
Symptom Checklist 90 revised (SCL-90R; Subscale General Symptom Index, GSI)Change between intake (t1) and end of treatment (t2) in general distress symptoms within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)
Comorbid Diagnoses by DIA-X-InterviewChange between intake (t1) and end of treatment (t2) in number of comorbid psychiatric diagnoses within 5 months; t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026